Source: Annual Congress 2003 - Management of acute exacerbations in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. N. Makaryants, A. E. Ergeshov, I. E. Stepanyan, E. I. Shmelev (Moscow, Russia). Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2003; 22: Suppl. 45, 1602

Member's Comments

No comment yet.

Related content which might interest you: The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Use of telehealth in the management of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Source: Guideline 1995 Year: 1995 Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)? Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Cilomilast is efficacious in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 68s Year: 2003 Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment Year: 2013 Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 310s Year: 2005 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 The evaluation of a helpline for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2004 - Smoking and cessation in respiratory disease Year: 2004 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Reasons for hospitalisation patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 473s Year: 2002